|
EP1782826A1
(en)
|
2005-11-08 |
2007-05-09 |
GBF Gesellschaft für Biotechnologische Forschung mbH |
PQS and c-diGMP and its conjugates as adjuvants and their uses in pharmaceutical compositions
|
|
US8067237B2
(en)
|
2005-12-13 |
2011-11-29 |
President And Fellows Of Harvard College |
Scaffolds for cell transplantation
|
|
US9370531B2
(en)
*
|
2007-08-31 |
2016-06-21 |
New York University |
Method of providing patient specific immune response in amyloidoses and protein aggregation disorders
|
|
WO2009105641A2
(en)
*
|
2008-02-20 |
2009-08-27 |
New York University |
Preventing and treating amyloid-beta deposition by stimulation of innate immunity
|
|
US9019549B2
(en)
*
|
2008-11-26 |
2015-04-28 |
Xerox Corporation |
Exception page programming for banner sheets
|
|
CN102199183B
(zh)
*
|
2010-03-26 |
2013-12-18 |
北京大学 |
环二鸟苷酸及其类似物和制备方法
|
|
US8450293B2
(en)
*
|
2010-08-10 |
2013-05-28 |
Rutgers, The State University Of New Jersey |
Synthesis and characterization of C8 analogs of c-di-GMP
|
|
CA2813751C
(en)
|
2010-10-06 |
2019-11-12 |
President And Fellows Of Harvard College |
Injectable, pore-forming hydrogels for materials-based cell therapies
|
|
US9675561B2
(en)
|
2011-04-28 |
2017-06-13 |
President And Fellows Of Harvard College |
Injectable cryogel vaccine devices and methods of use thereof
|
|
JP5650780B2
(ja)
*
|
2012-04-04 |
2015-01-07 |
日東電工株式会社 |
ワクチン組成物
|
|
CN107137357B
(zh)
|
2012-04-16 |
2020-11-24 |
哈佛学院董事会 |
用于调节免疫反应的介孔二氧化硅组合物
|
|
CN104507538B
(zh)
|
2012-06-08 |
2018-04-06 |
艾杜罗生物科技公司 |
癌症免疫疗法的组合物和方法
|
|
US9090646B2
(en)
*
|
2012-12-05 |
2015-07-28 |
Rutgers, The State University Of New Jersey |
Biotinylated compounds
|
|
SG11201502796RA
(en)
*
|
2012-12-13 |
2015-05-28 |
Aduro Biotech Inc |
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
|
|
WO2014099824A1
(en)
*
|
2012-12-19 |
2014-06-26 |
Board Of Regents, The University Of Texas System |
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
|
|
EP3662927A3
(en)
|
2013-02-05 |
2020-10-21 |
Nitto Denko Corporation |
Vaccine composition
|
|
RU2697443C2
(ru)
|
2013-02-05 |
2019-08-14 |
Нитто Денко Корпорейшн |
Препарат противораковой вакцины, содержащий пептид wt1, в форме ленты трансдермального введения
|
|
CA2841016A1
(en)
|
2013-02-05 |
2014-08-05 |
Nitto Denko Corporation |
Wt1 peptide cancer vaccine composition for transdermal administration
|
|
US10206985B2
(en)
|
2013-02-05 |
2019-02-19 |
Nitto Denko Corporation |
WT1 peptide cancer vaccine composition for mucosal administration
|
|
US20140220100A1
(en)
|
2013-02-05 |
2014-08-07 |
Nitto Denko Corporation |
Vaccine composition for transdermal administration
|
|
CN103961698A
(zh)
|
2013-02-05 |
2014-08-06 |
日东电工株式会社 |
经皮或粘膜给予用疫苗组合物
|
|
EP2762152A1
(en)
|
2013-02-05 |
2014-08-06 |
Nitto Denko Corporation |
WT1 peptide cancer vaccine composition for transdermal administration
|
|
CN103961306A
(zh)
|
2013-02-05 |
2014-08-06 |
日东电工株式会社 |
经皮给予用疫苗组合物
|
|
RU2014102948A
(ru)
|
2013-02-05 |
2015-08-10 |
Нитто Денко Корпорейшн |
Вакцинная композиция для мукозального введения
|
|
KR20140099828A
(ko)
|
2013-02-05 |
2014-08-13 |
닛토덴코 가부시키가이샤 |
점막 투여용 백신 조성물
|
|
CA2908154C
(en)
*
|
2013-04-29 |
2023-11-28 |
Memorial Sloan Kettering Cancer Center |
Compositions and methods for altering second messenger signaling
|
|
JP2016518140A
(ja)
*
|
2013-05-03 |
2016-06-23 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
Ｉ型インターフェロンの環状ジヌクレオチド誘導法
|
|
CU24377B1
(es)
*
|
2013-05-18 |
2018-12-05 |
Aduro Biotech Inc |
Dinucléotidos de purina cíclicos y composiciones de los mismos útiles para inducir la producción de interferón de tipo i dependientes de sting
|
|
US9549944B2
(en)
|
2013-05-18 |
2017-01-24 |
Aduro Biotech, Inc. |
Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling
|
|
US10176292B2
(en)
|
2013-07-31 |
2019-01-08 |
Memorial Sloan-Kettering Cancer Center |
STING crystals and modulators
|
|
WO2015074145A1
(en)
|
2013-11-22 |
2015-05-28 |
Brock University |
Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants
|
|
US9315523B2
(en)
|
2013-12-06 |
2016-04-19 |
Rutgers, The State University Of New Jersey |
Cyclic dinucleosides
|
|
CN103908468B
(zh)
*
|
2014-04-21 |
2017-02-08 |
上海捌加壹医药科技有限公司 |
环二核苷酸cGAMP在制备抗肿瘤药物中的应用
|
|
US10682400B2
(en)
|
2014-04-30 |
2020-06-16 |
President And Fellows Of Harvard College |
Combination vaccine devices and methods of killing cancer cells
|
|
KR20170015353A
(ko)
|
2014-06-04 |
2017-02-08 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
Ｓｔｉｎｇ의 조절제로서 사이클릭 디뉴클레오타이드
|
|
US10010607B2
(en)
|
2014-09-16 |
2018-07-03 |
Institut Curie |
Method for preparing viral particles with cyclic dinucleotide and use of said particles for inducing immune response
|
|
GB201501462D0
(en)
|
2015-01-29 |
2015-03-18 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
WO2016123573A1
(en)
|
2015-01-30 |
2016-08-04 |
President And Fellows Of Harvard College |
Peritumoral and intratumoral materials for cancer therapy
|
|
JP6692826B2
(ja)
|
2015-03-10 |
2020-05-13 |
アドゥロ バイオテック，インク． |
「インターフェロン遺伝子刺激因子」依存性シグナル伝達の活性化のための組成物及び方法
|
|
EP3280464A4
(en)
|
2015-04-10 |
2018-09-26 |
President and Fellows of Harvard College |
Immune cell trapping devices and methods for making and using the same
|
|
US11453697B1
(en)
|
2015-08-13 |
2022-09-27 |
Merck Sharp & Dohme Llc |
Cyclic di-nucleotide compounds as sting agonists
|
|
BR112018002757A8
(pt)
*
|
2015-08-13 |
2023-04-11 |
Merck Sharp & Dohme |
Composto, composição farmacêutica, e, métodos para induzir uma resposta imune, para induzir uma produção de interferon tipo i e para tratamento de um distúrbio
|
|
JP6411676B2
(ja)
|
2015-12-03 |
2018-10-24 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
Ｓｔｉｎｇの調節因子としての環状プリンジヌクレオチド
|
|
CN106540260A
(zh)
*
|
2015-12-09 |
2017-03-29 |
聊城市奥润生物医药科技有限公司 |
干扰素基因刺激蛋白（sting）激动剂在抗阿尔兹海默症中的应用
|
|
KR20250049441A
(ko)
*
|
2016-01-11 |
2025-04-11 |
인네이트 튜머 이뮤니티, 인코포레이티드 |
Sting 활성과 연관된 상태 예컨대 암의 치료를 위한 시클릭 디뉴클레오티드
|
|
US10723756B2
(en)
|
2016-01-11 |
2020-07-28 |
Innate Tumor Immunity Inc. |
Cyclic dinucleotides for treating conditions associated with STING activity such as cancer
|
|
CN115487351A
(zh)
|
2016-02-06 |
2022-12-20 |
哈佛学院校长同事会 |
重塑造血巢以重建免疫
|
|
KR20180127402A
(ko)
*
|
2016-03-16 |
2018-11-28 |
인스티튜트 큐리 |
사이클릭 디뉴클레오타이드를 포함하는 바이러스 입자의 제조 방법 및 암 치료를 위한 상기 입자의 용도
|
|
NZ746112A
(en)
|
2016-03-18 |
2023-01-27 |
Immune Sensor Llc |
Cyclic di-nucleotide compounds and methods of use
|
|
ES2921855T3
(es)
|
2016-04-07 |
2022-09-01 |
Glaxosmithkline Ip Dev Ltd |
Amidas heterocíclicas útiles como moduladores de proteínas
|
|
RU2018137389A
(ru)
|
2016-04-07 |
2020-05-12 |
Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Гетероциклические амиды, полезные в качестве модуляторов
|
|
US10696985B1
(en)
|
2016-06-06 |
2020-06-30 |
Vanderbilt University |
Reversibly crosslinked endosomolytic polymer vesicles for cytosolic drug delivery
|
|
US11098077B2
(en)
|
2016-07-05 |
2021-08-24 |
Chinook Therapeutics, Inc. |
Locked nucleic acid cyclic dinucleotide compounds and uses thereof
|
|
AU2017293781B2
(en)
*
|
2016-07-06 |
2022-12-22 |
Invox Pharma Limited |
Compounds, compositions, and methods for the treatment of disease
|
|
DK3484448T3
(da)
|
2016-07-13 |
2025-06-10 |
Harvard College |
Antigenpræsenterende cellemimetiske stilladser og fremgangsmåder til fremstilling og brug af disse
|
|
WO2018013924A1
(en)
|
2016-07-15 |
2018-01-18 |
Massachusetts Institute Of Technology |
Synthetic nanoparticles for delivery of immunomodulatory compounds
|
|
NL2017267B1
(en)
|
2016-07-29 |
2018-02-01 |
Aduro Biotech Holdings Europe B V |
Anti-pd-1 antibodies
|
|
JP7274214B2
(ja)
|
2016-08-02 |
2023-05-16 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
免疫応答を調節するための生体材料
|
|
NL2017270B1
(en)
|
2016-08-02 |
2018-02-09 |
Aduro Biotech Holdings Europe B V |
New anti-hCTLA-4 antibodies
|
|
US10537590B2
(en)
*
|
2016-09-30 |
2020-01-21 |
Boehringer Ingelheim International Gmbh |
Cyclic dinucleotide compounds
|
|
EP3523287B1
(en)
|
2016-10-04 |
2021-09-01 |
Merck Sharp & Dohme Corp. |
Benzo[b]thiophene compounds as sting agonists
|
|
CA3038810A1
(en)
|
2016-10-11 |
2018-04-19 |
The Governors Of The University Of Alberta |
Hepatitis c virus immunogenic compositions and methods of use thereof
|
|
JOP20170192A1
(ar)
|
2016-12-01 |
2019-01-30 |
Takeda Pharmaceuticals Co |
داي نوكليوتيد حلقي
|
|
US20200055883A1
(en)
|
2017-02-17 |
2020-02-20 |
Eisai R&D Management Co., Ltd. |
Cyclic di-nucleotides derivative for the treatment of cancer
|
|
JOP20190218A1
(ar)
|
2017-03-22 |
2019-09-22 |
Boehringer Ingelheim Int |
مركبات ثنائية النيوكليوتيدات حلقية معدلة
|
|
IL315837A
(en)
|
2017-04-13 |
2024-11-01 |
Sairopa B V |
Anti-SIRP-alpha antibodies
|
|
EP3610022A1
(en)
|
2017-04-14 |
2020-02-19 |
Tollnine, Inc. |
Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use
|
|
UY37695A
(es)
|
2017-04-28 |
2018-11-30 |
Novartis Ag |
Compuesto dinucleótido cíclico bis 2’-5’-rr-(3’f-a)(3’f-a) y usos del mismo
|
|
EP3621624B1
(en)
|
2017-05-12 |
2023-08-30 |
Merck Sharp & Dohme LLC |
Cyclic di-nucleotide compounds as sting agonists
|
|
WO2018232217A1
(en)
|
2017-06-16 |
2018-12-20 |
William Marsh Rice University |
Hydrogel delivery of sting immunotherapy for treatment of cancer
|
|
KR102709265B1
(ko)
*
|
2017-07-28 |
2024-09-23 |
브리스톨-마이어스 스큅 컴퍼니 |
항암제로서의 시클릭 디뉴클레오티드
|
|
RU2020109328A
(ru)
|
2017-08-04 |
2021-09-06 |
Мерк Шарп И Доум Корп. |
Комбинации антагонистов pd-1 и бензо[b]тиофеновых агонистов sting для лечения рака
|
|
EP3661498A4
(en)
|
2017-08-04 |
2021-04-21 |
Merck Sharp & Dohme Corp. |
BENZO [B] THIOPHEN STING ANTAGONISTS FOR CANCER TREATMENT
|
|
CA3073919A1
(en)
|
2017-08-30 |
2019-03-07 |
Beijing Xuanyi Pharmasciences Co., Ltd. |
Cyclic di-nucleotides as stimulator of interferon genes modulators
|
|
WO2019051488A1
(en)
|
2017-09-11 |
2019-03-14 |
Sperovie Biosciences, Inc. |
COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISEASE
|
|
WO2019051489A1
(en)
|
2017-09-11 |
2019-03-14 |
Sperovie Biosciences, Inc. |
COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISEASE
|
|
CA3076337A1
(en)
|
2017-09-19 |
2019-03-28 |
Massachusetts Institute Of Technology |
Compositions for chimeric antigen receptor t cell therapy and uses thereof
|
|
US11377440B2
(en)
|
2017-10-05 |
2022-07-05 |
Glaxosmithkline Intellectual Property Development Limited |
Modulators of stimulator of interferon genes (STING)
|
|
US20210238172A1
(en)
|
2017-10-05 |
2021-08-05 |
Glaxosmithkline Intellectual Property Development Limited |
Heterocyclic amides useful as protein modulators and methods of using the same
|
|
EP3691640A1
(en)
|
2017-10-05 |
2020-08-12 |
GlaxoSmithKline Intellectual Property Development Limited |
Methods for administering sting agonists
|
|
MX2020004858A
(es)
|
2017-11-10 |
2020-10-01 |
Takeda Pharmaceuticals Co |
Compuestos moduladores de sting y metodos de elaboracion y uso.
|
|
US11685761B2
(en)
|
2017-12-20 |
2023-06-27 |
Merck Sharp & Dohme Llc |
Cyclic di-nucleotide compounds as sting agonists
|
|
US12220462B1
(en)
|
2018-02-13 |
2025-02-11 |
Abionyx Pharma Sa |
Complexes for delivery of cyclic dinucleotides
|
|
JP2021519279A
(ja)
|
2018-03-27 |
2021-08-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
修飾環式ジヌクレオチド化合物
|
|
CN111971291A
(zh)
|
2018-03-27 |
2020-11-20 |
勃林格殷格翰国际有限公司 |
用作sting激动剂的含有2-氮杂-次黄嘌呤或6h-吡唑并[1,5-d][1,2,4]三嗪-7-酮的环状二核苷酸化合物
|
|
US11702430B2
(en)
|
2018-04-03 |
2023-07-18 |
Merck Sharp & Dohme Llc |
Aza-benzothiophene compounds as STING agonists
|
|
EP3774764A1
(en)
|
2018-04-03 |
2021-02-17 |
Merck Sharp&Dohme Corp. |
Benzothiophenes and related compounds as sting agonists
|
|
CN108670975A
(zh)
*
|
2018-04-28 |
2018-10-19 |
杭州星鳌生物科技有限公司 |
内质网受体蛋白激活剂在制备免疫增强剂药物中的应用
|
|
GB201807924D0
(en)
|
2018-05-16 |
2018-06-27 |
Ctxt Pty Ltd |
Compounds
|
|
BR112020024605A2
(pt)
|
2018-06-01 |
2021-04-06 |
Eisai R&D Management Co., Ltd. |
Métodos para o tratamento de câncer de bexiga
|
|
WO2020014127A1
(en)
|
2018-07-10 |
2020-01-16 |
Sperovie Biosciences, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
|
BR112021001349A2
(pt)
|
2018-08-16 |
2021-04-20 |
Eisai R&D Management Co., Ltd. |
sais de compostos e cristais dos mesmos
|
|
WO2020049534A1
(en)
|
2018-09-07 |
2020-03-12 |
Novartis Ag |
Sting agonist and combination therapy thereof for the treatment of cancer
|
|
WO2020061129A1
(en)
|
2018-09-19 |
2020-03-26 |
President And Fellows Of Harvard College |
Compositions and methods for labeling and modulation of cells in vitro and in vivo
|
|
WO2020092633A1
(en)
|
2018-10-30 |
2020-05-07 |
Vanderbilt University |
Graft copolymers, methods of forming graft copolymers, and methods of use thereof
|
|
TW202104214A
(zh)
|
2019-04-05 |
2021-02-01 |
英商葛蘭素史密斯克藍智慧財產發展有限公司 |
化合物
|
|
JP7621974B2
(ja)
|
2019-05-09 |
2025-01-27 |
アリゴス セラピューティクス インコーポレイテッド |
Ｓｔｉｎｇモジュレータとしての修飾環状ジヌクレオシド化合物
|
|
GB201910304D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
|
GB201910305D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
|
US12098212B2
(en)
|
2019-08-12 |
2024-09-24 |
Purinomia Biotech, Inc. |
Methods and compositions for promoting and potentiating T-cell mediated immune responses through ADCC targeting of CD39 expressing cells
|
|
WO2021074695A1
(en)
|
2019-10-16 |
2021-04-22 |
Avacta Life Sciences Limited |
PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES.
|
|
CN114981265B
(zh)
|
2019-12-18 |
2025-01-03 |
Ctxt私人有限公司 |
化合物
|
|
US12251449B2
(en)
|
2019-12-19 |
2025-03-18 |
William Marsh Rice University |
Synthetic multidomain peptide biomaterials that inhibit inducible nitric oxide synthase
|
|
IL295759A
(en)
|
2020-02-28 |
2022-10-01 |
Tallac Therapeutics Inc |
Transglutaminase mediated coupling
|
|
WO2021221782A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Chimeric antigen receptor-targeting ligands and uses thereof
|
|
WO2021221783A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
|
|
JP7072604B2
(ja)
*
|
2020-06-23 |
2022-05-20 |
アンスティテュ・クリー |
環状ジヌクレオチドを含むウイルス粒子を調製する方法及びがんを治療するための前記粒子の使用
|
|
TW202233251A
(zh)
|
2020-11-09 |
2022-09-01 |
日商武田藥品工業股份有限公司 |
抗體藥物綴合物
|
|
CN116981479A
(zh)
|
2020-12-17 |
2023-10-31 |
塔夫茨大学信托人 |
Fap激活的放射治疗诊断法以及与之相关的用途
|
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
|
US20250243277A1
(en)
|
2021-10-07 |
2025-07-31 |
Avacta Life Sciences Limited |
Pd-l1 binding affimers
|
|
JP2025509191A
(ja)
|
2022-03-04 |
2025-04-11 |
マサチューセッツ インスティテュート オブ テクノロジー |
経粘膜性の両親媒性物質－タンパク質コンジュゲートワクチン
|
|
WO2023218243A1
(en)
|
2022-05-12 |
2023-11-16 |
Avacta Life Sciences Limited |
Lag-3/pd-l1 binding fusion proteins
|
|
CN115300617A
(zh)
*
|
2022-08-08 |
2022-11-08 |
上海交通大学医学院附属仁济医院 |
一种多价适配体修饰的装载有sting激动剂的肿瘤疫苗及其制备方法和应用
|